FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915017368> ?p ?o ?g. }

• W2915017368 endingPage "e0211784" @default.
• W2915017368 startingPage "e0211784" @default.
• W2915017368 abstract "Introduction There is a high global incidence of typhoid fever, with an annual mortality rate of 200,000 deaths. Typhoid fever also affects younger children, particularly in resource-limited settings in endemic countries. Typhoid vaccination is an important prevention tool against typhoid fever. However, the available polysaccharide typhoid vaccines are not recommended for children under 2 years of age. A new typhoid conjugate Vi-diphtheria toxoid (Vi-DT) vaccine has been developed for infant immunization. We aimed to define the safety and immunogenicity of the Vi-DT vaccine among adults and children in Indonesia. Methods An observational, blinded, comparative, randomized, phase I safety study in two age de-escalating cohorts was conducted in East Jakarta, Indonesia, from April 2017 to February 2018. We enrolled 100 healthy subjects in 2 age groups: adults and children (18–40 and 2–5 years old). These groups were randomized into study groups (Vi-DT vaccine), and comparator groups (Vi-polysaccharide (Vi-PS) vaccine and another additional vaccine) which was administered in 4 weeks apart. Subjects were followed up to six months. Result One hundred healthy adults and children subjects completed the study. The Vi-DT and Vi-PS vaccines showed no difference in terms of intensity of any immediate local and systemic events within 30 minutes post-vaccination. Overall, pain was the most common local reaction, and muscle pain was the most common systemic reaction in the first 72 hours. No serious adverse events were deemed related to vaccine administration. The first and second doses of the Vi-DT vaccine induced seroconversion and higher geometric mean titers (GMT) in all subjects compared to that of baseline. However, in terms of GMT, the second dose of Vi-DT did not induce a booster response. Conclusion The Vi-DT vaccine is safe and immunogenic in adults and children older than two years. A single dose of the vaccine is able to produce seroconversion and high GMT in all individuals." @default.
• W2915017368 created "2019-02-21" @default.
• W2915017368 creator A5001276814 @default.
• W2915017368 creator A5005490903 @default.
• W2915017368 creator A5016115558 @default.
• W2915017368 creator A5028005100 @default.
• W2915017368 creator A5042246071 @default.
• W2915017368 creator A5044946797 @default.
• W2915017368 creator A5045402223 @default.
• W2915017368 creator A5050729780 @default.
• W2915017368 creator A5054951758 @default.
• W2915017368 creator A5057085178 @default.
• W2915017368 creator A5060047209 @default.
• W2915017368 creator A5064784510 @default.
• W2915017368 creator A5076039500 @default.
• W2915017368 creator A5081145803 @default.
• W2915017368 date "2019-02-13" @default.
• W2915017368 modified "2023-10-18" @default.
• W2915017368 title "Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine" @default.
• W2915017368 cites W1975800092 @default.
• W2915017368 cites W2000893610 @default.
• W2915017368 cites W2021755623 @default.
• W2915017368 cites W2026301364 @default.
• W2915017368 cites W2038218236 @default.
• W2915017368 cites W2049532298 @default.
• W2915017368 cites W2065122103 @default.
• W2915017368 cites W2101698593 @default.
• W2915017368 cites W2102898060 @default.
• W2915017368 cites W2107158542 @default.
• W2915017368 cites W2114213575 @default.
• W2915017368 cites W2115048812 @default.
• W2915017368 cites W2119388453 @default.
• W2915017368 cites W2128396797 @default.
• W2915017368 cites W2142245535 @default.
• W2915017368 cites W2142999073 @default.
• W2915017368 cites W2147278081 @default.
• W2915017368 cites W2195372528 @default.
• W2915017368 cites W2335972457 @default.
• W2915017368 cites W2340127586 @default.
• W2915017368 cites W2415729072 @default.
• W2915017368 cites W2766349877 @default.
• W2915017368 cites W2805895293 @default.
• W2915017368 cites W2808668519 @default.
• W2915017368 cites W4243637892 @default.
• W2915017368 cites W4250873783 @default.
• W2915017368 cites W4253282092 @default.
• W2915017368 cites W4254002014 @default.
• W2915017368 cites W4297835529 @default.
• W2915017368 cites W4299811586 @default.
• W2915017368 doi "https://doi.org/10.1371/journal.pone.0211784" @default.
• W2915017368 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6373931" @default.
• W2915017368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30759132" @default.
• W2915017368 hasPublicationYear "2019" @default.
• W2915017368 type Work @default.
• W2915017368 sameAs 2915017368 @default.
• W2915017368 citedByCount "15" @default.
• W2915017368 countsByYear W29150173682020 @default.
• W2915017368 countsByYear W29150173682021 @default.
• W2915017368 countsByYear W29150173682022 @default.
• W2915017368 countsByYear W29150173682023 @default.
• W2915017368 crossrefType "journal-article" @default.
• W2915017368 hasAuthorship W2915017368A5001276814 @default.
• W2915017368 hasAuthorship W2915017368A5005490903 @default.
• W2915017368 hasAuthorship W2915017368A5016115558 @default.
• W2915017368 hasAuthorship W2915017368A5028005100 @default.
• W2915017368 hasAuthorship W2915017368A5042246071 @default.
• W2915017368 hasAuthorship W2915017368A5044946797 @default.
• W2915017368 hasAuthorship W2915017368A5045402223 @default.
• W2915017368 hasAuthorship W2915017368A5050729780 @default.
• W2915017368 hasAuthorship W2915017368A5054951758 @default.
• W2915017368 hasAuthorship W2915017368A5057085178 @default.
• W2915017368 hasAuthorship W2915017368A5060047209 @default.
• W2915017368 hasAuthorship W2915017368A5064784510 @default.
• W2915017368 hasAuthorship W2915017368A5076039500 @default.
• W2915017368 hasAuthorship W2915017368A5081145803 @default.
• W2915017368 hasBestOaLocation W29150173681 @default.
• W2915017368 hasConcept C126322002 @default.
• W2915017368 hasConcept C147483822 @default.
• W2915017368 hasConcept C159047783 @default.
• W2915017368 hasConcept C168563851 @default.
• W2915017368 hasConcept C187212893 @default.
• W2915017368 hasConcept C197934379 @default.
• W2915017368 hasConcept C203014093 @default.
• W2915017368 hasConcept C22070199 @default.
• W2915017368 hasConcept C2776714567 @default.
• W2915017368 hasConcept C2777351567 @default.
• W2915017368 hasConcept C2779583294 @default.
• W2915017368 hasConcept C2779841045 @default.
• W2915017368 hasConcept C2780799908 @default.
• W2915017368 hasConcept C2780801004 @default.
• W2915017368 hasConcept C2780868878 @default.
• W2915017368 hasConcept C520601542 @default.
• W2915017368 hasConcept C71924100 @default.
• W2915017368 hasConceptScore W2915017368C126322002 @default.
• W2915017368 hasConceptScore W2915017368C147483822 @default.
• W2915017368 hasConceptScore W2915017368C159047783 @default.
• W2915017368 hasConceptScore W2915017368C168563851 @default.
• W2915017368 hasConceptScore W2915017368C187212893 @default.

• next